Tirz
What is Tirz?
Tirz, also known as GLP2-T, is a synthetic dual GIP and GLP-1 receptor agonist studied for its effects on metabolic signaling, insulin pathways, and energy-balance regulation. In research environments, it is investigated for its ability to modulate incretin signaling, receptor crosstalk, and systemic hormone interactions, making it a compound of interest in experimental models focused on glucose regulation, energy metabolism, and integrated endocrine responses.
Certificate of Analysis
Third-party tested for 99% purity
GLP2-T Overview
GLP2-T (tirzepatide) is a dual GIP and GLP-1 receptor agonist investigated for its ability to influence metabolic signaling, insulin pathways, and energy-balance regulation. By simultaneously engaging GIP and GLP-1 receptors, tirzepatide enables researchers to explore:
- Synergistic incretin signaling
- Insulin-related pathway modulation
- Cellular and systemic hormone interactions
This dual-agonist approach represents an important advancement in incretin research, allowing the study of integrated endocrine signaling rather than isolated receptor activity.
Frias J.P. et al., 2021History and Development
The development of GLP2-T is rooted in decades of incretin research that began with the identification of GLP-1 and GIP as key regulators of glucose homeostasis. Following the success of GLP-1 receptor agonists, researchers expanded toward dual-agonist strategies to investigate coordinated incretin signaling.
Tirzepatide was synthesized in the 2010s as a novel investigational compound with balanced activity at both GIP and GLP-1 receptors, designed to explore synergistic metabolic and endocrine effects.
Coskun T. et al., 2018Tirzepatide Structure
Research Findings
GLP2-T (tirzepatide) has been examined across structural, metabolic, molecular, and endocrine research models. Published studies explore its influence on insulin secretion dynamics, glucose regulation, receptor signaling, and intracellular hormone crosstalk.
Key Areas of Investigation
- Incretin Pathways: GIP and GLP-1 receptor activation
- Metabolic: Energy balance, glucose-related signaling
- Cellular: Receptor activity, intracellular response pathways
- Molecular: Hormone signaling integration, pathway crosstalk
Collectively, these findings suggest broad experimental utility for tirzepatide across metabolic, cellular, and molecular research domains. By engaging multiple hormone receptors simultaneously, GLP2-T provides a versatile research platform for studying glucose regulation, energy metabolism, and integrated hormonal biology.
Frias J.P. et al., NEJM 2021
